Comparability of MMPI-3 scores from remote and in-person administrations and the impact of the COVID-19 pandemic on MMPI-3 scores.

The COVID-19 pandemic onset necessitated remote administration of psychological instruments, including the Minnesota Multiphasic Personality Inventory-3 (MMPI-3). Although previous evidence has demonstrated that MMPI scale scores are robust across administration modalities, the specific effects of remote administration on the psychometric properties of MMPI-3 scale scores must be investigated. Distinguishing psychometric differences due to administration modality from substantive changes in psychological symptoms due to the COVID-19 pandemic is also important. Thus, goals of the present study include evaluating the psychometric comparability of MMPI-3 scores derived from in-person and remote administration modalities and examining substantive scale scores changes associated with the COVID-19 pandemic. Using a large sample of college students (n = 2,503), rates of protocol invalidity, mean scale scores, reliability, and criterion validity were compared across participants completing the MMPI-3 in-person (both prior to and after the onset of COVID-19) and via remote administration. Results demonstrate comparably low rates of protocol invalidity, negligible differences in reliability, and similar patterns of criterion validity for MMPI-3 scale scores across administration modalities. Results also indicate that mean MMPI-3 scale scores pre- and post-COVID-19 onset substantially differ on select scales, but that scores on remote and in-person protocols administered post-COVID-19 have negligible differences. Remote MMPI-3 scale scores also demonstrated expected patterns of correlations with external criteria, supporting the validity of remote scores. Overall, the present study demonstrates that MMPI-3 protocols administered remotely and in-person are extremely psychometrically similar, although scores have generally increased post-COVID-19 onset for reasons independent of administration modality. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

The utility of the MMPI-3 in predicting substance use related problems in a clinical neuropsychology sample.

Assessing for problematic substance use in neuropsychological assessments is crucial for differential diagnosis and attribution of symptom causes. The current investigation examines the utility of the Minnesota Multiphasic Personality Inventory-3 (MMPI-3 in predicting such substance use in a clinical neuropsychology sample. Participants included 208 outpatient neuropsychological examinees. Correlations and risk ratios were calculated for externalizing-psychopathology-related scales and external substance use criteria. Hierarchical regressions examined the incremental prediction of criteria by MMPI-3 externalizing scales above the Substance Abuse (SUB) scale. Results indicate that MMPI-3 externalizing scales are associated with substance-use-related criteria as conceptually expected. Additionally, we report significantly increased risk of experiencing substance-use-related problems at various T score elevations on multiple externalizing scales. Finally, SUB served as the primary predictor of substance-use-related criteria. These findings support the ability of the MMPI-3 to assess for past or current substance use and negative consequences of substance use in a clinical neuropsychology setting.